NFKB1 and type 2 diabetes mellitus: Zhang et al. [14] demonstrated that transcription factors in the STAT/nuclear factor κB (NF-κB)/IRF families, in combination with miR-148a/375/9a, act as key regulators of inflammation and apoptosis pathways in type 2 diabetes mellitus (T2DM) rats treated with DOE.